NEW YORK (GenomeWeb News) – An international group of translational research organizations that includes the Scripps Research Institute have teamed up to form a new partnership that will collaborate on projects and share resources and expertise, the UK non-profit MRC Technology said today.
The Global Alliance of Leading Drug and Discovery and Development Centres was started by six founding member organizations that have deep alliances with partners in the biopharmaceutical industry. They hope to harness these collaborations to improve best practices and develop commons standards and measurements to improve translational research.
In addition to Scripps and MRC Technology, the other partners in the program include organizations that are involved in a wide range of research, development, and commercialization activities, including Canada's Centre for Drug Research and Development (CDRD); Germany's Lead Discovery Center; the Centre for Drug Design and Discovery in Belgium; and the UK's development and commercialization specialist Cancer Research Technology.
"We see a multitude of translational research initiatives around the world, but until now, these have for the most part, worked in isolation of one another," CDRD President and CEO Karimah Es Sabar said in a statement. "This alliance will be a powerful vehicle in bringing such organizations together, leveraging one another's strengths, and ultimately making for a much more effective global translational research environment."